At the University of Konstanz a novel method with very high selectivity has been developed, which allows the inclusion of amino acids with nucleic acid-intercalating properties into proteins and peptides. Protein- and peptide-based active pharmaceutical components often contain structures that act as intercalators. The technology uses standard protein expression methods and only requires the presence of the ncAA in the medium and the co-expression of the respective aminoacyl-tRNA synthetases as well as the tRNA. The invention has substantial potential for the development of new applications and products, in particular in the pharmaceutical and biotech fields.
Further information: PDF
Technologie-Lizenz-Büro (TLB) der Baden-Württembergischen Hochschulen GmbH
Phone: +49 (0)721/79 00 40
Dipl.-Biol. Marcus Lehnen, MBA
As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.
firstname.lastname@example.org | TechnologieAllianz e.V.
New Lithium Salts of Pentafluorophenylamide Anions as Electrolytes in Lithium Ionic Batteries
18.04.2017 | TechnologieAllianz e.V.
Gratings on glass surfaces
28.03.2017 | TechnologieAllianz e.V.
23.05.2017 | Event News
22.05.2017 | Event News
17.05.2017 | Event News
23.05.2017 | Physics and Astronomy
23.05.2017 | Life Sciences
23.05.2017 | Medical Engineering